252 related articles for article (PubMed ID: 20963455)
1. The pathogenic role of Maillard reaction in the aging eye.
Nagaraj RH; Linetsky M; Stitt AW
Amino Acids; 2012 Apr; 42(4):1205-20. PubMed ID: 20963455
[TBL] [Abstract][Full Text] [Related]
2. The maillard reaction in eye diseases.
Stitt AW
Ann N Y Acad Sci; 2005 Jun; 1043():582-97. PubMed ID: 16037281
[TBL] [Abstract][Full Text] [Related]
3. Too sweet: Problems of protein glycation in the eye.
Bejarano E; Taylor A
Exp Eye Res; 2019 Jan; 178():255-262. PubMed ID: 30145354
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic uses of drug-carrier systems for imidazole-containing dipeptide compounds that act as pharmacological chaperones and have significant impact on the treatment of chronic diseases associated with increased oxidative stress and the formation of advanced glycation end products.
Babizhayev MA; Yegorov YE
Crit Rev Ther Drug Carrier Syst; 2010; 27(2):85-154. PubMed ID: 20486899
[TBL] [Abstract][Full Text] [Related]
5. Maillard reactions by alpha-oxoaldehydes: detection of glyoxal-modified proteins.
Sady C; Jiang CL; Chellan P; Madhun Z; Duve Y; Glomb MA; Nagaraj RH
Biochim Biophys Acta; 2000 Sep; 1481(2):255-64. PubMed ID: 11018716
[TBL] [Abstract][Full Text] [Related]
6. Advanced glycation and advanced lipoxidation: possible role in initiation and progression of diabetic retinopathy.
Stitt AW; Frizzell N; Thorpe SR
Curr Pharm Des; 2004; 10(27):3349-60. PubMed ID: 15544520
[TBL] [Abstract][Full Text] [Related]
7. Advanced glycation as a basis for understanding retinal aging and noninvasive risk prediction.
Pawlak AM; Glenn JV; Beattie JR; McGarvey JJ; Stitt AW
Ann N Y Acad Sci; 2008 Apr; 1126():59-65. PubMed ID: 18448796
[TBL] [Abstract][Full Text] [Related]
8. Advanced Glycation End-Products and Diabetic Neuropathy of the Retina.
Oshitari T
Int J Mol Sci; 2023 Feb; 24(3):. PubMed ID: 36769249
[TBL] [Abstract][Full Text] [Related]
9. New biomarkers of Maillard reaction damage to proteins.
Wells-Knecht KJ; Brinkmann E; Wells-Knecht MC; Litchfield JE; Ahmed MU; Reddy S; Zyzak DV; Thorpe SR; Baynes JW
Nephrol Dial Transplant; 1996; 11 Suppl 5():41-7. PubMed ID: 9044306
[TBL] [Abstract][Full Text] [Related]
10. The role of advanced glycation in the pathogenesis of diabetic retinopathy.
Stitt AW
Exp Mol Pathol; 2003 Aug; 75(1):95-108. PubMed ID: 12834631
[TBL] [Abstract][Full Text] [Related]
11. Glycation and insolubility of human lens protein.
Kamei A
Chem Pharm Bull (Tokyo); 1992 Oct; 40(10):2787-91. PubMed ID: 1464110
[TBL] [Abstract][Full Text] [Related]
12. The role of advanced glycation end products in retinal ageing and disease.
Glenn JV; Stitt AW
Biochim Biophys Acta; 2009 Oct; 1790(10):1109-16. PubMed ID: 19409449
[TBL] [Abstract][Full Text] [Related]
13. Advanced glycation and retinal pathology during diabetes.
Stitt AW; Curtis TM
Pharmacol Rep; 2005; 57 Suppl():156-68. PubMed ID: 16415497
[TBL] [Abstract][Full Text] [Related]
14. Protein Repair from Glycation by Glyoxals by the DJ-1 Family Maillard Deglycases.
Mihoub M; Abdallah J; Richarme G
Adv Exp Med Biol; 2017; 1037():133-147. PubMed ID: 29147907
[TBL] [Abstract][Full Text] [Related]
15. Role of the Maillard reaction in diabetes mellitus and diseases of aging.
Thorpe SR; Baynes JW
Drugs Aging; 1996 Aug; 9(2):69-77. PubMed ID: 8820792
[TBL] [Abstract][Full Text] [Related]
16. Maillard Proteomics: Opening New Pages.
Soboleva A; Schmidt R; Vikhnina M; Grishina T; Frolov A
Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29231845
[TBL] [Abstract][Full Text] [Related]
17. Mechanistic targeting of advanced glycation end-products in age-related diseases.
Rowan S; Bejarano E; Taylor A
Biochim Biophys Acta Mol Basis Dis; 2018 Dec; 1864(12):3631-3643. PubMed ID: 30279139
[TBL] [Abstract][Full Text] [Related]
18. The Development of Maillard Reaction, and Advanced Glycation End Product (AGE)-Receptor for AGE (RAGE) Signaling Inhibitors as Novel Therapeutic Strategies for Patients with AGE-Related Diseases.
Shen CY; Lu CH; Wu CH; Li KJ; Kuo YM; Hsieh SC; Yu CL
Molecules; 2020 Nov; 25(23):. PubMed ID: 33261212
[TBL] [Abstract][Full Text] [Related]
19. DNA-aptamers raised against AGEs as a blocker of various aging-related disorders.
Yamagishi S; Taguchi K; Fukami K
Glycoconj J; 2016 Aug; 33(4):683-90. PubMed ID: 27338620
[TBL] [Abstract][Full Text] [Related]
20. [Maillard reaction. Pathogenic effects].
Voyer LE; Alvarado C
Medicina (B Aires); 2019; 79(2):137-143. PubMed ID: 31048279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
